# ğŸ“Š å°ˆç§‘è©•åˆ†å·¥å…·è¦†è“‹ç¼ºå£åˆ†æ

> **æœ€å¾Œæ›´æ–°**: 2026-01-08
> **åˆ†æä¾æ“š**: 
>   - Specialty enum (76 å€‹å°ˆç§‘) vs å·²å¯¦ä½œè¨ˆç®—å™¨ (91 å€‹)
>   - Cochrane Library ç³»çµ±æ€§å›é¡§
>   - å„å­¸æœƒè‡¨åºŠæŒ‡å¼•

---

## ğŸ“ˆ ç¸½é«”è¦†è“‹ç‹€æ³

### âœ… è¦†è“‹è‰¯å¥½çš„å°ˆç§‘ (æœ‰å¤šå€‹è©•åˆ†å·¥å…·)

| å°ˆç§‘ | å·²å¯¦ä½œå·¥å…·æ•¸ | ä»£è¡¨å·¥å…· |
|------|-------------|---------|
| **Critical Care** | 15+ | SOFA, SOFA-2, qSOFA, APACHE II, NEWS2, RASS, CAM-ICU, ICDSC, NUTRIC |
| **Cardiology** | 12+ | CHAâ‚‚DSâ‚‚-VASc, CHAâ‚‚DSâ‚‚-VA, HAS-BLED, HEART, GRACE, EuroSCORE II, HFA-PEFF, SCORE2 |
| **Anesthesiology** | 8+ | ASA, RCRI, Mallampati, STOP-BANG, Apfel, Aldrete, MABL |
| **Neurology** | 7+ | GCS, NIHSS, mRS, ABCD2, Hunt & Hess, Fisher, 4AT |
| **Hepatology** | 6 | Child-Pugh, MELD, MELD-Na, FIB-4, Maddrey DF, Lille Model |
| **Pulmonology** | 6+ | CURB-65, PSI/PORT, ROX Index, P/F Ratio, Murray Score, sPESI |
| **Gastroenterology** | 3 | Rockall, Glasgow-Blatchford, AIMS65 |
| **Emergency Medicine** | 5+ | qSOFA, NEWS2, HEART, Wells DVT/PE |
| **Trauma** | 5+ | GCS, ISS, RTS, TRISS, ç‡’å‚· (Parkland, TBSA) |
| **Pediatrics** | 4+ | PEWS, pSOFA (Phoenix), PIM-3, Pediatric GCS |

### âš ï¸ éƒ¨åˆ†è¦†è“‹çš„å°ˆç§‘ (æœ‰ 1-2 å€‹å·¥å…·)

| å°ˆç§‘ | å·²å¯¦ä½œå·¥å…· | ç¼ºå£å»ºè­° |
|------|-----------|---------|
| **Nephrology** | CKD-EPI 2021, KDIGO AKI | Renal Failure Index, AKIN |
| **Oncology** | ECOG PS, Karnofsky | TNM staging helper? |
| **Nutrition** | NRS-2002, NUTRIC | MUST, SGA |
| **Rheumatology** | DAS28 | CDAI, SDAI, ACR/EULAR criteria |
| **Bone Health** | FRAX | NOGG, Garvan |
| **Geriatrics** | 4AT, Karnofsky | Clinical Frailty Scale, MNA |

### âŒ è¦†è“‹ä¸è¶³æˆ–ç„¡è¦†è“‹çš„å°ˆç§‘

| å°ˆç§‘ | å»ºè­°å„ªå…ˆå¯¦ä½œçš„å·¥å…· | Cochrane æ”¯æŒ | å„ªå…ˆç´š |
|------|-------------------|---------------|--------|
| **Psychiatry** | PHQ-9, GAD-7, HAM-D, CAPS | âœ… PMID:33956992 | ğŸ”´ é«˜ |
| **Dermatology** | PASI, SCORAD, DLQI | âœ… PMID:35603936 | ğŸ”´ é«˜ |
| **Endocrinology** | FINDRISC, Thyroid Eye Disease CAS | âœ… PMID:32470201 | ğŸŸ¡ ä¸­ |
| **Urology** | IPSS, AUA-SI, ICIQ-SF | âœ… PMID:37070660 | ğŸŸ¡ ä¸­ |
| **Obstetrics** | Bishop Score, TACO Score, sFlt-1/PlGF | âŒ | ğŸŸ¡ ä¸­ |
| **Ophthalmology** | Visual Acuity scales, IOP criteria | âŒ | ğŸŸ¢ ä½ |
| **ENT** | Centor/McIsaac, Epworth Sleepiness Scale | âŒ | ğŸŸ¢ ä½ |
| **Orthopedics** | WOMAC, Harris Hip Score | âŒ | ğŸŸ¢ ä½ |
| **Infectious Disease** | MASCC, Pitt Bacteremia Score | âŒ | ğŸŸ¡ ä¸­ |

---

## ğŸ¯ æŒ‰å„ªå…ˆç´šå»ºè­°å¯¦ä½œçš„è©•åˆ†å·¥å…·

### Phase 24: ç²¾ç¥ç§‘è©•åˆ†å·¥å…· (Psychiatry Scores)

| å·¥å…· | å…¨å | ç”¨é€” | Cochrane æ”¯æŒ |
|------|------|------|---------------|
| **PHQ-9** | Patient Health Questionnaire-9 | æ†‚é¬±ç—‡ç¯©æª¢/è¿½è¹¤ | PMID:33956992 |
| **GAD-7** | Generalized Anxiety Disorder-7 | ç„¦æ…®ç—‡ç¯©æª¢ | - |
| **HAM-D** | Hamilton Depression Rating Scale | æ†‚é¬±ç—‡åš´é‡åº¦ | PMID:33956992 |
| **HAM-A** | Hamilton Anxiety Rating Scale | ç„¦æ…®ç—‡åš´é‡åº¦ | - |
| **MADRS** | Montgomery-Ã…sberg Depression Rating Scale | æ†‚é¬±ç—‡è¿½è¹¤ | - |
| **CAPS** | Clinician-Administered PTSD Scale | PTSD è©•ä¼° | PMID:35234292 |
| **PCL-5** | PTSD Checklist for DSM-5 | PTSD è‡ªè©• | PMID:35234292 |

### Phase 25: çš®è†šç§‘è©•åˆ†å·¥å…· (Dermatology Scores)

| å·¥å…· | å…¨å | ç”¨é€” | Cochrane æ”¯æŒ |
|------|------|------|---------------|
| **PASI** | Psoriasis Area and Severity Index | ä¹¾ç™¬åš´é‡åº¦ | PMID:35603936 |
| **SCORAD** | SCORing Atopic Dermatitis | ç•°ä½æ€§çš®è†šç‚ | PMID:36373988 |
| **DLQI** | Dermatology Life Quality Index | çš®è†šç—…ç”Ÿæ´»å“è³ª | å¤šç¯‡ |
| **SALT** | Severity of Alopecia Tool | ç¦¿é ­ç—‡åš´é‡åº¦ | PMID:37870096 |
| **BSA** | Body Surface Area | çš®è†šå—å½±éŸ¿é¢ç© | - |

### Phase 26: å…§åˆ†æ³Œ/ä»£è¬è©•åˆ†å·¥å…·

| å·¥å…· | å…¨å | ç”¨é€” | Cochrane æ”¯æŒ |
|------|------|------|---------------|
| **FINDRISC** | Finnish Diabetes Risk Score | ç¬¬äºŒå‹ç³–å°¿ç—…é¢¨éšª | PMID:32470201 |
| **NDS/NSS** | Neuropathy Disability/Symptom Score | ç³–å°¿ç—…ç¥ç¶“ç—…è®Š | PMID:38205823 |
| **Toronto CSS** | Toronto Clinical Scoring System | ç³–å°¿ç—…ç¥ç¶“ç—…è®Š | - |
| **CAS** | Clinical Activity Score | ç”²ç‹€è…ºçœ¼ç—… | - |
| **Cushingoid Score** | Cushingoid Features Score | åº«æ¬£ç—‡å€™ç¾¤ | - |

### Phase 27: æ³Œå°¿ç§‘è©•åˆ†å·¥å…·

| å·¥å…· | å…¨å | ç”¨é€” | Cochrane æ”¯æŒ |
|------|------|------|---------------|
| **IPSS/AUA-SI** | International Prostate Symptom Score | æ”è­·è…ºè‚¥å¤§ç—‡ç‹€ | - |
| **ICIQ-SF** | ICIQ Short Form | å°¿å¤±ç¦è©•ä¼° | PMID:37070660 |
| **STONE Score** | - | è¼¸å°¿ç®¡çµçŸ³ | - |
| **Bosniak Classification** | - | è…å›Šè…«åˆ†é¡ | - |

### Phase 28: å©¦ç”¢ç§‘è©•åˆ†å·¥å…·

| å·¥å…· | å…¨å | ç”¨é€” | Cochrane æ”¯æŒ |
|------|------|------|---------------|
| **Bishop Score** | - | å­å®®é ¸æˆç†Ÿåº¦ | - |
| **Apgar Score** | - | æ–°ç”Ÿå…’è©•ä¼° | å·²åœ¨å°å…’ç§‘? |
| **Edinburgh Postnatal Depression Scale** | EPDS | ç”¢å¾Œæ†‚é¬±ç¯©æª¢ | - |
| **sFlt-1/PlGF Ratio** | - | å­ç™²å‰ç—‡é æ¸¬ | - |
| **POP-Q** | Pelvic Organ Prolapse Quantification | éª¨ç›†è„«å‚åˆ†æœŸ | PMID:37493538 |

### Phase 29: æ„ŸæŸ“ç§‘è©•åˆ†å·¥å…·

| å·¥å…· | å…¨å | ç”¨é€” | å‚™è¨» |
|------|------|------|------|
| **MASCC Score** | - | ç™¼ç†±æ€§å—œä¸­æ€§çƒä½ä¸‹é¢¨éšª | è…«ç˜¤æ„ŸæŸ“ |
| **Pitt Bacteremia Score** | - | èŒè¡€ç—‡åš´é‡åº¦ | - |
| **Pneumonia Severity Index (PSI)** | - | è‚ºç‚åš´é‡åº¦ | âœ… å·²æœ‰ |
| **CURB-65** | - | è‚ºç‚åš´é‡åº¦ | âœ… å·²æœ‰ |

### Phase 30: è€å¹´é†«å­¸è©•åˆ†å·¥å…·

| å·¥å…· | å…¨å | ç”¨é€” | å‚™è¨» |
|------|------|------|------|
| **Clinical Frailty Scale (CFS)** | - | è¡°å¼±è©•ä¼° | Rockwood |
| **MNA** | Mini Nutritional Assessment | ç‡Ÿé¤Šè©•ä¼° | è€å¹´äºº |
| **MMSE** | Mini-Mental State Examination | èªçŸ¥åŠŸèƒ½ | Cochrane é©—è­‰ |
| **MoCA** | Montreal Cognitive Assessment | èªçŸ¥åŠŸèƒ½ | - |
| **Timed Up and Go (TUG)** | - | è¡Œå‹•èƒ½åŠ› | è·Œå€’é¢¨éšª |
| **Barthel Index** | - | æ—¥å¸¸ç”Ÿæ´»åŠŸèƒ½ | - |

---

## ğŸ“‹ ç¾æœ‰ Specialty Enum vs è¨ˆç®—å™¨å°æ‡‰

| Specialty Enum | å·²æœ‰è¨ˆç®—å™¨ | å»ºè­°è£œå…… |
|----------------|-----------|---------|
| `PSYCHIATRY` | âŒ ç„¡ | PHQ-9, GAD-7, HAM-D |
| `DERMATOLOGY` | âŒ ç„¡ | PASI, SCORAD, DLQI |
| `ENDOCRINOLOGY` | âŒ ç„¡ | FINDRISC, NDS |
| `UROLOGY` | âŒ ç„¡ | IPSS, ICIQ-SF |
| `OPHTHALMOLOGY` | âŒ ç„¡ | VA, IOP |
| `ENT` | âŒ ç„¡ | Centor, Epworth |
| `ORTHOPEDICS` | âŒ ç„¡ | WOMAC, Harris |
| `OBSTETRICS` | âŒ ç„¡ | Bishop, EPDS |
| `GYNECOLOGY` | âŒ ç„¡ | POP-Q |
| `INFECTIOUS_DISEASE` | âŒ ç„¡ | MASCC, Pitt |
| `RHEUMATOLOGY` | âœ… DAS28 | CDAI, SDAI |
| `HEMATOLOGY` | âŒ ç„¡ | IPSS-R (MDS) |
| `ALLERGY_IMMUNOLOGY` | âŒ ç„¡ | Asthma Control Test |

---

## ğŸ“Š è¦†è“‹ç‡çµ±è¨ˆ

### ç•¶å‰ç‹€æ…‹
- **Specialty enum ç¸½æ•¸**: 76 å€‹
- **æœ‰å°æ‡‰è¨ˆç®—å™¨çš„å°ˆç§‘**: ~15 å€‹ (~20%)
- **å·²å¯¦ä½œè¨ˆç®—å™¨ç¸½æ•¸**: 91 å€‹
- **è¨ˆç®—å™¨åˆ†å¸ƒ**: ä¸»è¦é›†ä¸­åœ¨é‡ç—‡ã€å¿ƒè‡Ÿã€éº»é†‰ã€ç¥ç¶“ã€è‚è‡Ÿ

### ç›®æ¨™ç‹€æ…‹ (Phase 30 å®Œæˆå¾Œ)
- **é è¨ˆæ–°å¢è¨ˆç®—å™¨**: ~35 å€‹
- **ç¸½è¨ˆç®—å™¨æ•¸**: ~126 å€‹
- **å°ˆç§‘è¦†è“‹ç‡**: ~40% (30/76)

---

## ğŸ—“ï¸ å»ºè­°é–‹ç™¼æ™‚ç¨‹

| Phase | å°ˆç§‘ | å·¥å…·æ•¸ | é è¨ˆæ™‚é–“ |
|-------|------|--------|---------|
| Phase 24 | Psychiatry | 7 | 1 é€± |
| Phase 25 | Dermatology | 5 | 3 å¤© |
| Phase 26 | Endocrinology | 5 | 3 å¤© |
| Phase 27 | Urology | 4 | 2 å¤© |
| Phase 28 | Obstetrics/Gynecology | 5 | 3 å¤© |
| Phase 29 | Infectious Disease | 2 | 1 å¤© |
| Phase 30 | Geriatrics | 6 | 3 å¤© |

**ç¸½è¨ˆ**: ~34 å€‹æ–°å·¥å…·ï¼Œç´„ 2-3 é€±é–‹ç™¼æ™‚é–“

---

## ğŸ“š åƒè€ƒè³‡æº

### Cochrane å›é¡§ (å·²æœå°‹)
- PMID: 37987526 - CAM-ICU è¨ºæ–·æº–ç¢ºåº¦
- PMID: 34931303 - RCRI + Biomarkers
- PMID: 34313331 - MMSE è¨ºæ–·æº–ç¢ºåº¦
- PMID: 33956992 - Depression prognosis models
- PMID: 35603936 - Psoriasis treatments (PASI)
- PMID: 32470201 - DM screening (FINDRISC)

### ä¸»è¦æŒ‡å¼•
- ESC Guidelines (å¿ƒè‡Ÿç§‘)
- SCCM/SSC Guidelines (é‡ç—‡)
- APA Guidelines (ç²¾ç¥ç§‘)
- AAD Guidelines (çš®è†šç§‘)
- ADA/EASD Guidelines (å…§åˆ†æ³Œ)

---

*æ­¤æ–‡ä»¶å°‡éš¨æ–°é–‹ç™¼é€²åº¦æŒçºŒæ›´æ–°*
*Generated by Copilot Analysis*
*Last Update: 2026-01-08*
